Hypopigmentation Disorders Treatment Market by Treatment Type (Topical Drugs, Chemical Peels, Laser Therapy, and Microdermabrasion), Disease Indication (Albinism, and Vitiligo), End User (Dermatology Centers, Aesthetic Clinics, and Hospitals) - Analysis & Forecast 2019-2030

Report ID : 38  |  Published Date : Mar 2019  |  Pages : 150  |  Region : Global  |  Report Code : MD-21




Hypopigmentation Disorders Treatment Market Overview and Introduction

The global hypopigmentation disorder treatment market is anticipated to reach a CAGR over 5.5% during the forecast period. Hypopigmentation is a skin condition, where the skin looses the color or skin pigments due to decrease in melanin or melanocyte. The formation of pigmented skins may occur in patches or all over the body. Although, hypopigmentation may occur among people of all races, but the occurrence of such a condition is more noticeable among individuals with dark complexion.

The global hypopigmentation disorders treatment market is driven by technological advancements in the pigmentation treatment and therapy arena, increasing patient awareness and health care expenditure, and rising geriatric population. Rising adoption of minimally invasive treatment procedure, increasing medical tourism for aesthetics has been crucial in contributing to increasing growth of the hypopigmentation disorders treatment market. Similarly, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo, is anticipated to further contribute to the rising demand of global hypopigmentation disorder treatment market. However, high cost, complications & risk associated with medical aesthetics products and treatment is likely to restrain the market to a certain extent. 

Hypopigmentation Disorders Treatment Market  by Treatment Type

On the basis of treatment type, the hypopigmentation disorders treatment market is segmented into topical drugs, chemical peels, laser therapy, microdermabrasion and other treatments. The segment of topical drugs is anticipated to account for the largest share in the hypopigmentation disorders treatments market, owing to wide scale prescription of topical treatment options by dermatologists worldwide.

Hypopigmentation Disorders Treatment Market by Disease Indication 

The segment of disease indication can be segmented into albinism, vitiligo indications and other disease indications. Vitiligo segment is constituted a substantial share in 2018, owing to rising incidences of vitiligo and increasing patient population undergoing treatment of the same.

Hypopigmentation Disorders Treatment Market by End Users 

Finally, on the basis of end user, the hypopigmentation disorders treatments market is segmented into dermatology centers, aesthetic clinics, and hospitals, and other end user.

Hypopigmentation Disorders Treatment Market by Regions 

The global hypopigmentation disorders treatment market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America dominated the hypopigmentation disorders treatment market, followed by Europe and Asia Pacific. Asia Pacific will continue to dominate the global hypopigmentation disorders treatments market in the forecast period owing to factors such as growing adoption of minimally-invasive procedures, rising consciousness regarding ones looks, high healthcare expenditures and highly developed healthcare system. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries, penetration and adoption of latest technologies, increasing disposable incomes and growing government support are driving the growth of the hypopigmentation disorders treatments market in this region.

Hypopigmentation Disorders Treatment Market Prominent Players 

The prominent players in the global hypopigmentation disorders treatments market are ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, Inc., RXi Pharmaceuticals, Obagi Cosmeceuticals LLC., and Alvogen among others

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.   Market Classification
      2.   Geographic Scope
      3.   Years Considered for the Study
        1. Historical Years – 2016 & 2017
        2. Base Year – 2018
        3. Forecasted Years – 2019 to 2030
    3. Currency Used for the Study
    4. Report Beneficiary List
  2.   RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.   Secondary Sources
      2.   Primary Sources
    4. Market Estimation Methodology
      1.   Bottoms Up Approach
      2.   Top Down Approach
    5. Data Validation and Triangulation
      1.   Market Forecasting Model
      2.   Limitations of the Study
      3.   Assumptions of the Study
  3.    ABSTRACT OF THE STUDY
  4.    MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Technological Advancements
    2. Winning Imperatives (Top Success Factors Assessment)
    3. Pipeline Assessment
  6. GLOBAL HYPOPIGMENTATION DISORDERS TREATMENT MARKET - ANALYSIS & FORECAST, BY TREATMENT TYPE
    1. Topical Drugs
    2. Chemical Peels
    3. Laser Therapy
    4. Microdermabrasion
    5. Other Treatments
  7. GLOBAL HYPOPIGMENTATION DISORDERS TREATMENT MARKET - ANALYSIS & FORECAST, BY DISEASE INDICATION
    1. Introduction 
    2. Albinism
    3. Vitiligo
    4. Other Disease Indications
  8. GLOBAL HYPOPIGMENTATION DISORDERS TREATMENT MARKET - ANALYSIS & FORECAST, BY END USER
    1. Introduction 
    2. Dermatology Centers
    3. Aesthetic Clinics
    4. Hospitals
    5. Other End Users
  9. GLOBAL HYPOPIGMENTATION DISORDERS TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1.     North America Hypopigmentation Disorders Treatment Market
      1.   North America Hypopigmentation Disorders Treatment Market, By Country
        1.  US
        2.  Canada
      2. North America Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Treatment Type
      3. North America Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Disease Indication
      4. North America Hypopigmentation Disorders Treatment Market Analysis & Forecast, By End User
    2. Europe Hypopigmentation Disorders Treatment Market
      1. Europe Hypopigmentation Disorders Treatment Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Treatment Type
      3. Europe Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Disease Indication
      4. Europe Hypopigmentation Disorders Treatment Market Analysis & Forecast, By End User
    3. Asia Pacific Hypopigmentation Disorders Treatment Market
      1. Asia Pacific Hypopigmentation Disorders Treatment Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Treatment Type
      3. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Disease Indication
      4. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis & Forecast, By End User
    4.    Rest of the World (ROW) Hypopigmentation Disorders Treatment Market
      1. Rest of the World Hypopigmentation Disorders Treatment Market, By Country/ Region
        1.  Latin America
        2. Middle East & Africa
      2. Rest of the World Hypopigmentation Disorders Treatment Market Analysis & Forecast, By  Treatment Type
      3. Rest of the World Hypopigmentation Disorders Treatment Market Analysis & Forecast, By Disease Indication
      4. Rest of the World Hypopigmentation Disorders Treatment Market Analysis & Forecast, By End User
  10. COMPETETIVE LANDSCAPE ASSESSMENT
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Other Strategies
  11. COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance*, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)
    1.   ALLERGAN
    2.  SkinCeuticals International 
    3.    PIERRE FABRE GROUP
    4.    Episciences, Inc.
    5.    RXi Pharmaceuticals
    6.    Obagi Cosmeceuticals LLC.
    7.    Alvogen (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
  12. APPENDIX
    1. Questionnaire
    2. Primary Interviews Transcripts
    3.    Customization Options